- Home
- DIBS vs ALEC Comparison
DIBS vs ALEC Comparison
Compare DIBS & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DIBS | ALEC |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.9M | 200.8M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DIBS | ALEC |
|---|---|---|
| Price | $5.84 | $1.95 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 7 |
| Target Price | ★ $7.00 | $3.33 |
| AVG Volume (30 Days) | 165.0K | ★ 1.1M |
| Earning Date | 02-27-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $89,422,000.00 | $69,048,000.00 |
| Revenue This Year | $3.73 | N/A |
| Revenue Next Year | $2.21 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 3.49 | ★ 12.26 |
| 52 Week Low | $2.30 | $0.87 |
| 52 Week High | $6.63 | $3.40 |
Technical Indicators
Market Signals| Indicator | DIBS | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 54.98 | 69.71 |
| Support Level | $5.69 | $1.77 |
| Resistance Level | $6.20 | $2.00 |
| Average True Range (ATR) | 0.28 | 0.11 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 54.88 | 80.95 |
Price Performance
Historical ComparisonAbout DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.